Biovault is the only tissue bank in the UK providing full tissue banking services for both public and private sector organisations, giving us a breadth of experience our partners value.
For public sector/NHS bodies, outsourcing human tissue storage and processing is fast becoming a very cost-effective option and Biovault has unrivalled expertise in building successful partnerships. From the start, Biovault was conceived as a reproducible model and, by leveraging our proven expertise, we can create regional tissue banks in your area quickly and cost-effectively, each employing our fully compliant processes and systems.
Working with the UK National Health Service
Biovault is proud to be the tissue bank for the South-West Peninsula Transplant Service for peripheral blood and bone marrow stem cells transplants based at Derriford Hospital in Plymouth. During our collaboration, we have built a strong relationship with the Plymouth Hospitals NHS Trust, expanding the range of services we provide to include the processing and storage of other types of tissue, such as femoral heads for use in surgical hip revisions.
As a private tissue bank working directly with the NHS over a long period, Biovault understands the needs of NHS Trusts and we have developed a flexible, cost-effective service model to meet them. We can establish a regional human tissue storage and processing facility with low start-up costs under our existing licence from the Human Tissue Authority. There is no need to build a bespoke facility as our model can easily convert an existing building to meet the high regulatory standards.
A global reach
In addition to our expertise in working with public sector organisations, Biovault has extensive experience in working with private companies right across the world. Currently, we work with companies in Europe, North America, the Middle East and Asia, processing and storing a range of human tissues.
We understand the commercial pressures on private clinics, hospitals and cord blood agencies to deliver great value for their customers and we work hard to ensure that our high-quality storage services are provided at cost-effective prices.
BioVault was awarded JACIE accreditation in November 2011, an extremely proud achievement for us as we are the first private tissue bank to be awarded this accreditation in the UK. JACIE The Joint Accreditation Committee-ISCT & EBMT is a non profit body established in 1998 for the purposes of assessment and accreditation in the field of haematopoietic stem cell (HSC) transplantation.
BioVault holds an open ended, unconditional HTA licence which covers every aspect of all transplantable material for human application. For more detail concerning BioVault's HTA licence
(licence no: 11063)
The internationally recognised standard for an organisation's internal Quality Management.
(certificate no: GB04/62552)
Quality management standards for medical devices
(certificate no: GB07/72849)
BioVault's Flow Cytometers are externally quality controlled by NEQAS .
British Association of Tissue Banks
BioVault is an established member of the British Association of Tissue Banks
Biovault has also recently become a member of the ESBB, European, Middle Easter and African Society for Biopreservation and Biobanking. The mission of the ESBB is to advance the field of biobanking in support of research relating to healthcare, education and the environment.
Biovault has been issued the Certificate of Registration for the Community Trade Mark as of 24.12.2009 by The Office of Harmonization for the Internal Market. This is valid in all 27 countries of the EU.
Please find below few selected quotes from the final 'site visit inspection' report of 15 May 2012 by HTA. http://www.hta.gov.uk/_db/_documents/2012-03-07_11063.pdf
"Compliance with HTA standards"
"All applicable HTA standards have been assessed as fully met."
"The DI and CLHC have a good understanding of regulatory requirements. Staff at the establishment demonstrate a strong commitment to meeting HTA requirements and to the ongoing development of a culture of continuous improvement."
Records are owned by BioVault but are held in a fully-serviced commercial data centre under a commercial contract.
Records are multi-backed-up the system is resilient, robust, fast and infinitely expandable.
Record storage is full pre-paid for a 55 year period and access is guaranteed.
BioVault operates a fully compliant records system.
Future storage charges are escrowed and drawn down annually. The funds are controlled by an independent professional and not implicated should BioVault cease to exist and hence available for future storage.